Stocks involved in homeland security and military support continue to garner interest among leading advisors. Jocelynn Drake, Vahan Janjigian, Paul Tracy, and Ian Wyatt all see an opportunity in body armor manufacturer, DHB Industries.
(for more on the advisors cited below, please click on their photos.)
"DHB Industries (DHB ASE) specializes in selling body armor to the
military and other federal and state agencies," notes Vahan Janjigian,
editor of The Forbes Growth Investor.
"Its concealable armor is worn
beneath clothing and is resistant to smaller caliber bullets. Its tactical armor
is worn over clothing and protects against larger projectiles. DHB also
makes protective vests for dogs. There are risks with this stock. Although the
war on terror and hostilities in Iraq are likely to keep demand strong
for DHB’s protective armor, possible changes in scale and scope of the military budget
always pose a risk. Further, DHB faces stiff competition. In addition, we note
that the SEC is currently investigating issues relating to
executive compensation, although at this time, we do not expect this investigation to have
a significant impact. We are more focused on the fact that near-term
prospects are exceptionally strong. The company is expanding manufacturing
operations, it keeps winning major contract awards, and analysts keep raising
earnings expectations."
"In October alone, orders for the DHB's new line of body armor
topped $75 million," says Paul Tracy, editor of
StreetAuthority Market Advisor.
"This new line, dubbed Dorsal Auxiliary Protection System (DAPS), is designed to protect the underarm and
shoulders, areas that are often left unprotected by most conventional body armor vests.
The DAPS system received the largest contract ever awarded for body armor, a
near $300 million order from the US Army. And it's not
just the military that's buying. DHB also supplies armor to domestic law
enforcement agencies like the California Highway Patrol and the FBI. When the company reported second-quarter
earnings back in early August, its backlog stood at nearly $400 million. We expect that
the backlog is now almost equal to DHB's entire market cap of
a little over $600 million. The stock is one of our favorites in the
defense sector."
"DHB Industries recently reported third quarter financial results
that were marked by a 64% increase in revenues," notes Ian Wyatt, editor
of The Growth Stock Report. "The company earned $8 million or
$0.18 per share, on sales of $89.4 million, exceeding consensus estimates.
Earnings for the quarter grew 157%. The company also raised guidance for
2004, and is now expecting revenues of $330 million, up from its earlier
estimate of $300 million. About 40% of the company's backlog is for non-military
customers. This marks a significant improvement in the company's diversification
of clientele. We are pleased with these results and feel that the company
continues to move in the right direction. The additional orders are impressive
to say the least and speak toward DHB's continued dominance of the body armor
market. We maintain our Buy rating."
"Technically, DHB shares have rallied along the support of their
10-week and 20-week moving average since January 2003 and are now trading at a
new all-time high," says Jocelyn Drake, analyst with Schaeffer's
Investment Research. "The equity has also enjoyed the support of its
10-month moving average since April 2003. Despite the security's stellar
technical performance, the shares continue to hover below the Street's radar.
Only two analysts currently follow the shares and any additional
coverage could add some lift to the stock price. Short sellers are starting
to capitulate, as the number of DHB shares sold short dropped by 8% in October
to 4.1 million shares. However, this accumulation of bearish bets still accounts
for more than 17% of the security's float. An unwinding of these pessimistic
positions could also add some fuel to the security's rally. This enticing
combination of lingering skepticism against the stock's growing technical
strength has bullish implications from a contrarian
perspective."